MoneyWorks4Me

Hikal informs about disclosure

29 Nov 2025 Evaluate
Pursuant to Regulation 30 read with Schedule III Part A Para A and Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Hikal has enclosed the following documents: 1. Copies of newspaper advertisement published in Business Standard (English), Mumbai Lakshadeep (Marathi) on November 29, 2025. 2. Copy of reminder letter to shareholders. The above reminder letters were sent to the shareholders who have not claimed their dividends for seven or more consecutive years and whose shares are liable for transfer to the IEPF Authority. This is pursuant to Section 124(6) of the Companies Act, 2013 read with the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016, as amended. This intimation is also being made available on the website of the Company at www.hikal.com.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..